O
Orthopediatrics Corp (KIDS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$31.50
-0.85 (-2.63%)
Market Cap: $844.67M
Last updated: Nov 17, 2026 at 11:05 AM ET
Orthopediatrics Corp (KIDS) Valuation Multiples
Orthopediatrics (KIDS) trades at 2.9x sales and 2.2x book value. Its P/S of 2.9x is below its 5-year median of 4.1x.
Current Multiples
Its free cash flow yield is 0.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 2.9x |
| Price to book | 2.2x |
| Price to FCF | 239.3x |
| EV/FCF | 264.8x |
| PEG | N/A |
| FCF yield | 0.4% |
Historical Medians
Against its 10-year medians, its P/S is 57.4% below 6.8x and its P/B is 24.1% below 2.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.9x | 4.1x | 6.8x |
| P/B | 2.2x | 1.8x | 2.9x |
Valuation History
Over the 9 year ends shown, its P/S ranged from 1.2x in 2017 to 11.8x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $17.76 | 1.8x | 1.2x |
| 2024 | $23.18 | 2.6x | 1.5x |
| 2023 | $32.51 | 5.0x | 2.0x |
| 2022 | $39.73 | 6.7x | 2.4x |
| 2021 | $59.86 | 11.8x | 5.1x |
| 2020 | $41.25 | 10.5x | 3.4x |
| 2019 | $46.99 | 9.5x | 5.0x |
| 2018 | $34.88 | 7.6x | 5.6x |
| 2017 | $19.19 | 1.2x | 2.0x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About KIDS
Is KIDS stock overvalued?
GNG's valuation label for KIDS is Undervalued.
What is KIDS's price to sales ratio?
Orthopediatrics has a price to sales ratio of 2.9x.
KIDS pages: Overview, Earnings, Forecast, Financials, Valuation